カテゴリ： GlobalInfoResearch, 世界, 部品/材料

世界の医薬品用L-カルノシン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global L-Carnosine for Pharmaceutical Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO6511）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO6511
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の医薬品用L-カルノシン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

医薬品用L-カルノシン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の医薬品用L-カルノシンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

医薬品用L-カルノシン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・純度98%以上、純度99%以上、その他

用途別セグメントは次のように区分されます。
・健康補助食品、医薬品添加物、その他

世界の医薬品用L-カルノシン市場の主要な市場プレーヤーは以下のとおりです。
・Fushilai Pharmaceutical、Hamari Chemicals、Sinoway Industrial、Bachem、Belle Chemical、Xi'an Miracle Biotechnology、SUANFARMA、KS-V Peptide

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、医薬品用L-カルノシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医薬品用L-カルノシンメーカーの企業概要、2019年～2022年までの医薬品用L-カルノシンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医薬品用L-カルノシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別医薬品用L-カルノシンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの医薬品用L-カルノシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での医薬品用L-カルノシン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および医薬品用L-カルノシンの産業チェーンを掲載しています。
・第13、14、15章では、医薬品用L-カルノシンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 医薬品用L-カルノシンの概要
- 種類別分析（2017年vs2021年vs2028年）：純度98%以上、純度99%以上、その他
- 用途別分析（2017年vs2021年vs2028年）：健康補助食品、医薬品添加物、その他
- 世界の医薬品用L-カルノシン市場規模・予測
- 世界の医薬品用L-カルノシン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Fushilai Pharmaceutical、Hamari Chemicals、Sinoway Industrial、Bachem、Belle Chemical、Xi'an Miracle Biotechnology、SUANFARMA、KS-V Peptide
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：純度98%以上、純度99%以上、その他
・用途別分析2017年-2028年：健康補助食品、医薬品添加物、その他
・医薬品用L-カルノシンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・医薬品用L-カルノシンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・医薬品用L-カルノシンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・医薬品用L-カルノシンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・医薬品用L-カルノシンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The L-Carnosine for Pharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global L-Carnosine for Pharmaceutical market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Dietary Supplements accounting for % of the L-Carnosine for Pharmaceutical global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Purity Above 98% segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of L-Carnosine for Pharmaceutical include Fushilai Pharmaceutical, Hamari Chemicals, Sinoway Industrial, Bachem, and Belle Chemical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
L-Carnosine for Pharmaceutical market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Purity Above 98%
Purity Above 99%
Others
Market segment by Application can be divided into
Dietary Supplements
Pharmaceutical Additives
Others
The key market players for global L-Carnosine for Pharmaceutical market are listed below:
Fushilai Pharmaceutical
Hamari Chemicals
Sinoway Industrial
Bachem
Belle Chemical
Xi’an Miracle Biotechnology
SUANFARMA
KS-V Peptide
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe L-Carnosine for Pharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of L-Carnosine for Pharmaceutical, with price, sales, revenue and global market share of L-Carnosine for Pharmaceutical from 2019 to 2022.
Chapter 3, the L-Carnosine for Pharmaceutical competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the L-Carnosine for Pharmaceutical breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and L-Carnosine for Pharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of L-Carnosine for Pharmaceutical.
Chapter 13, 14, and 15, to describe L-Carnosine for Pharmaceutical sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 L-Carnosine for Pharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global L-Carnosine for Pharmaceutical Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Purity Above 98%
1.2.3 Purity Above 99%
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global L-Carnosine for Pharmaceutical Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Dietary Supplements
1.3.3 Pharmaceutical Additives
1.3.4 Others
1.4 Global L-Carnosine for Pharmaceutical Market Size & Forecast
1.4.1 Global L-Carnosine for Pharmaceutical Sales in Value (2017 & 2021 & 2028)
1.4.2 Global L-Carnosine for Pharmaceutical Sales in Volume (2017-2028)
1.4.3 Global L-Carnosine for Pharmaceutical Price (2017-2028)
1.5 Global L-Carnosine for Pharmaceutical Production Capacity Analysis
1.5.1 Global L-Carnosine for Pharmaceutical Total Production Capacity (2017-2028)
1.5.2 Global L-Carnosine for Pharmaceutical Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 L-Carnosine for Pharmaceutical Market Drivers
1.6.2 L-Carnosine for Pharmaceutical Market Restraints
1.6.3 L-Carnosine for Pharmaceutical Trends Analysis
2 Manufacturers Profiles
2.1 Fushilai Pharmaceutical
2.1.1 Fushilai Pharmaceutical Details
2.1.2 Fushilai Pharmaceutical Major Business
2.1.3 Fushilai Pharmaceutical L-Carnosine for Pharmaceutical Product and Services
2.1.4 Fushilai Pharmaceutical L-Carnosine for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Hamari Chemicals
2.2.1 Hamari Chemicals Details
2.2.2 Hamari Chemicals Major Business
2.2.3 Hamari Chemicals L-Carnosine for Pharmaceutical Product and Services
2.2.4 Hamari Chemicals L-Carnosine for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sinoway Industrial
2.3.1 Sinoway Industrial Details
2.3.2 Sinoway Industrial Major Business
2.3.3 Sinoway Industrial L-Carnosine for Pharmaceutical Product and Services
2.3.4 Sinoway Industrial L-Carnosine for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bachem
2.4.1 Bachem Details
2.4.2 Bachem Major Business
2.4.3 Bachem L-Carnosine for Pharmaceutical Product and Services
2.4.4 Bachem L-Carnosine for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Belle Chemical
2.5.1 Belle Chemical Details
2.5.2 Belle Chemical Major Business
2.5.3 Belle Chemical L-Carnosine for Pharmaceutical Product and Services
2.5.4 Belle Chemical L-Carnosine for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Xi’an Miracle Biotechnology
2.6.1 Xi’an Miracle Biotechnology Details
2.6.2 Xi’an Miracle Biotechnology Major Business
2.6.3 Xi’an Miracle Biotechnology L-Carnosine for Pharmaceutical Product and Services
2.6.4 Xi’an Miracle Biotechnology L-Carnosine for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 SUANFARMA
2.7.1 SUANFARMA Details
2.7.2 SUANFARMA Major Business
2.7.3 SUANFARMA L-Carnosine for Pharmaceutical Product and Services
2.7.4 SUANFARMA L-Carnosine for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 KS-V Peptide
2.8.1 KS-V Peptide Details
2.8.2 KS-V Peptide Major Business
2.8.3 KS-V Peptide L-Carnosine for Pharmaceutical Product and Services
2.8.4 KS-V Peptide L-Carnosine for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 L-Carnosine for Pharmaceutical Breakdown Data by Manufacturer
3.1 Global L-Carnosine for Pharmaceutical Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global L-Carnosine for Pharmaceutical Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in L-Carnosine for Pharmaceutical
3.4 Market Concentration Rate
3.4.1 Top 3 L-Carnosine for Pharmaceutical Manufacturer Market Share in 2021
3.4.2 Top 6 L-Carnosine for Pharmaceutical Manufacturer Market Share in 2021
3.5 Global L-Carnosine for Pharmaceutical Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and L-Carnosine for Pharmaceutical Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global L-Carnosine for Pharmaceutical Market Size by Region
4.1.1 Global L-Carnosine for Pharmaceutical Sales in Volume by Region (2017-2028)
4.1.2 Global L-Carnosine for Pharmaceutical Revenue by Region (2017-2028)
4.2 North America L-Carnosine for Pharmaceutical Revenue (2017-2028)
4.3 Europe L-Carnosine for Pharmaceutical Revenue (2017-2028)
4.4 Asia-Pacific L-Carnosine for Pharmaceutical Revenue (2017-2028)
4.5 South America L-Carnosine for Pharmaceutical Revenue (2017-2028)
4.6 Middle East and Africa L-Carnosine for Pharmaceutical Revenue (2017-2028)
5 Market Segment by Type
5.1 Global L-Carnosine for Pharmaceutical Sales in Volume by Type (2017-2028)
5.2 Global L-Carnosine for Pharmaceutical Revenue by Type (2017-2028)
5.3 Global L-Carnosine for Pharmaceutical Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global L-Carnosine for Pharmaceutical Sales in Volume by Application (2017-2028)
6.2 Global L-Carnosine for Pharmaceutical Revenue by Application (2017-2028)
6.3 Global L-Carnosine for Pharmaceutical Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America L-Carnosine for Pharmaceutical Sales by Type (2017-2028)
7.2 North America L-Carnosine for Pharmaceutical Sales by Application (2017-2028)
7.3 North America L-Carnosine for Pharmaceutical Market Size by Country
7.3.1 North America L-Carnosine for Pharmaceutical Sales in Volume by Country (2017-2028)
7.3.2 North America L-Carnosine for Pharmaceutical Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe L-Carnosine for Pharmaceutical Sales by Type (2017-2028)
8.2 Europe L-Carnosine for Pharmaceutical Sales by Application (2017-2028)
8.3 Europe L-Carnosine for Pharmaceutical Market Size by Country
8.3.1 Europe L-Carnosine for Pharmaceutical Sales in Volume by Country (2017-2028)
8.3.2 Europe L-Carnosine for Pharmaceutical Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific L-Carnosine for Pharmaceutical Sales by Type (2017-2028)
9.2 Asia-Pacific L-Carnosine for Pharmaceutical Sales by Application (2017-2028)
9.3 Asia-Pacific L-Carnosine for Pharmaceutical Market Size by Region
9.3.1 Asia-Pacific L-Carnosine for Pharmaceutical Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific L-Carnosine for Pharmaceutical Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America L-Carnosine for Pharmaceutical Sales by Type (2017-2028)
10.2 South America L-Carnosine for Pharmaceutical Sales by Application (2017-2028)
10.3 South America L-Carnosine for Pharmaceutical Market Size by Country
10.3.1 South America L-Carnosine for Pharmaceutical Sales in Volume by Country (2017-2028)
10.3.2 South America L-Carnosine for Pharmaceutical Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa L-Carnosine for Pharmaceutical Sales by Type (2017-2028)
11.2 Middle East & Africa L-Carnosine for Pharmaceutical Sales by Application (2017-2028)
11.3 Middle East & Africa L-Carnosine for Pharmaceutical Market Size by Country
11.3.1 Middle East & Africa L-Carnosine for Pharmaceutical Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa L-Carnosine for Pharmaceutical Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of L-Carnosine for Pharmaceutical and Key Manufacturers
12.2 Manufacturing Costs Percentage of L-Carnosine for Pharmaceutical
12.3 L-Carnosine for Pharmaceutical Production Process
12.4 L-Carnosine for Pharmaceutical Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 L-Carnosine for Pharmaceutical Typical Distributors
13.3 L-Carnosine for Pharmaceutical Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global L-Carnosine for Pharmaceutical Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global L-Carnosine for Pharmaceutical Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Fushilai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Fushilai Pharmaceutical Major Business
Table 5. Fushilai Pharmaceutical L-Carnosine for Pharmaceutical Product and Services
Table 6. Fushilai Pharmaceutical L-Carnosine for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Hamari Chemicals Basic Information, Manufacturing Base and Competitors
Table 8. Hamari Chemicals Major Business
Table 9. Hamari Chemicals L-Carnosine for Pharmaceutical Product and Services
Table 10. Hamari Chemicals L-Carnosine for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sinoway Industrial Basic Information, Manufacturing Base and Competitors
Table 12. Sinoway Industrial Major Business
Table 13. Sinoway Industrial L-Carnosine for Pharmaceutical Product and Services
Table 14. Sinoway Industrial L-Carnosine for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bachem Basic Information, Manufacturing Base and Competitors
Table 16. Bachem Major Business
Table 17. Bachem L-Carnosine for Pharmaceutical Product and Services
Table 18. Bachem L-Carnosine for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Belle Chemical Basic Information, Manufacturing Base and Competitors
Table 20. Belle Chemical Major Business
Table 21. Belle Chemical L-Carnosine for Pharmaceutical Product and Services
Table 22. Belle Chemical L-Carnosine for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Xi'an Miracle Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Xi'an Miracle Biotechnology Major Business
Table 25. Xi'an Miracle Biotechnology L-Carnosine for Pharmaceutical Product and Services
Table 26. Xi'an Miracle Biotechnology L-Carnosine for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. SUANFARMA Basic Information, Manufacturing Base and Competitors
Table 28. SUANFARMA Major Business
Table 29. SUANFARMA L-Carnosine for Pharmaceutical Product and Services
Table 30. SUANFARMA L-Carnosine for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. KS-V Peptide Basic Information, Manufacturing Base and Competitors
Table 32. KS-V Peptide Major Business
Table 33. KS-V Peptide L-Carnosine for Pharmaceutical Product and Services
Table 34. KS-V Peptide L-Carnosine for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global L-Carnosine for Pharmaceutical Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
Table 36. Global L-Carnosine for Pharmaceutical Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in L-Carnosine for Pharmaceutical, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global L-Carnosine for Pharmaceutical Production Capacity by Company, (Tons): 2020 VS 2021
Table 39. Head Office and L-Carnosine for Pharmaceutical Production Site of Key Manufacturer
Table 40. L-Carnosine for Pharmaceutical New Entrant and Capacity Expansion Plans
Table 41. L-Carnosine for Pharmaceutical Mergers & Acquisitions in the Past Five Years
Table 42. Global L-Carnosine for Pharmaceutical Sales by Region (2017-2022) & (Tons)
Table 43. Global L-Carnosine for Pharmaceutical Sales by Region (2023-2028) & (Tons)
Table 44. Global L-Carnosine for Pharmaceutical Revenue by Region (2017-2022) & (USD Million)
Table 45. Global L-Carnosine for Pharmaceutical Revenue by Region (2023-2028) & (USD Million)
Table 46. Global L-Carnosine for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 47. Global L-Carnosine for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 48. Global L-Carnosine for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 49. Global L-Carnosine for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 50. Global L-Carnosine for Pharmaceutical Price by Type (2017-2022) & (US$/Ton)
Table 51. Global L-Carnosine for Pharmaceutical Price by Type (2023-2028) & (US$/Ton)
Table 52. Global L-Carnosine for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 53. Global L-Carnosine for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 54. Global L-Carnosine for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 55. Global L-Carnosine for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 56. Global L-Carnosine for Pharmaceutical Price by Application (2017-2022) & (US$/Ton)
Table 57. Global L-Carnosine for Pharmaceutical Price by Application (2023-2028) & (US$/Ton)
Table 58. North America L-Carnosine for Pharmaceutical Sales by Country (2017-2022) & (Tons)
Table 59. North America L-Carnosine for Pharmaceutical Sales by Country (2023-2028) & (Tons)
Table 60. North America L-Carnosine for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 61. North America L-Carnosine for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 62. North America L-Carnosine for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 63. North America L-Carnosine for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 64. North America L-Carnosine for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 65. North America L-Carnosine for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 66. Europe L-Carnosine for Pharmaceutical Sales by Country (2017-2022) & (Tons)
Table 67. Europe L-Carnosine for Pharmaceutical Sales by Country (2023-2028) & (Tons)
Table 68. Europe L-Carnosine for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe L-Carnosine for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe L-Carnosine for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 71. Europe L-Carnosine for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 72. Europe L-Carnosine for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 73. Europe L-Carnosine for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 74. Asia-Pacific L-Carnosine for Pharmaceutical Sales by Region (2017-2022) & (Tons)
Table 75. Asia-Pacific L-Carnosine for Pharmaceutical Sales by Region (2023-2028) & (Tons)
Table 76. Asia-Pacific L-Carnosine for Pharmaceutical Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific L-Carnosine for Pharmaceutical Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific L-Carnosine for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 79. Asia-Pacific L-Carnosine for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 80. Asia-Pacific L-Carnosine for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 81. Asia-Pacific L-Carnosine for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 82. South America L-Carnosine for Pharmaceutical Sales by Country (2017-2022) & (Tons)
Table 83. South America L-Carnosine for Pharmaceutical Sales by Country (2023-2028) & (Tons)
Table 84. South America L-Carnosine for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 85. South America L-Carnosine for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 86. South America L-Carnosine for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 87. South America L-Carnosine for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 88. South America L-Carnosine for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 89. South America L-Carnosine for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 90. Middle East & Africa L-Carnosine for Pharmaceutical Sales by Region (2017-2022) & (Tons)
Table 91. Middle East & Africa L-Carnosine for Pharmaceutical Sales by Region (2023-2028) & (Tons)
Table 92. Middle East & Africa L-Carnosine for Pharmaceutical Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa L-Carnosine for Pharmaceutical Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa L-Carnosine for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 95. Middle East & Africa L-Carnosine for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 96. Middle East & Africa L-Carnosine for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 97. Middle East & Africa L-Carnosine for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 98. L-Carnosine for Pharmaceutical Raw Material
Table 99. Key Manufacturers of L-Carnosine for Pharmaceutical Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. L-Carnosine for Pharmaceutical Typical Distributors
Table 103. L-Carnosine for Pharmaceutical Typical Customers
List of Figures
Figure 1. L-Carnosine for Pharmaceutical Picture
Figure 2. Global L-Carnosine for Pharmaceutical Revenue Market Share by Type in 2021
Figure 3. Purity Above 98%
Figure 4. Purity Above 99%
Figure 5. Others
Figure 6. Global L-Carnosine for Pharmaceutical Revenue Market Share by Application in 2021
Figure 7. Dietary Supplements
Figure 8. Pharmaceutical Additives
Figure 9. Others
Figure 10. Global L-Carnosine for Pharmaceutical Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
Figure 11. Global L-Carnosine for Pharmaceutical Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global L-Carnosine for Pharmaceutical Sales (2017-2028) & (Tons)
Figure 13. Global L-Carnosine for Pharmaceutical Price (2017-2028) & (US$/Ton)
Figure 14. Global L-Carnosine for Pharmaceutical Production Capacity (2017-2028) & (Tons)
Figure 15. Global L-Carnosine for Pharmaceutical Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. L-Carnosine for Pharmaceutical Market Drivers
Figure 17. L-Carnosine for Pharmaceutical Market Restraints
Figure 18. L-Carnosine for Pharmaceutical Market Trends
Figure 19. Global L-Carnosine for Pharmaceutical Sales Market Share by Manufacturer in 2021
Figure 20. Global L-Carnosine for Pharmaceutical Revenue Market Share by Manufacturer in 2021
Figure 21. L-Carnosine for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 L-Carnosine for Pharmaceutical Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 L-Carnosine for Pharmaceutical Manufacturer (Revenue) Market Share in 2021
Figure 24. Global L-Carnosine for Pharmaceutical Sales Market Share by Region (2017-2028)
Figure 25. Global L-Carnosine for Pharmaceutical Revenue Market Share by Region (2017-2028)
Figure 26. North America L-Carnosine for Pharmaceutical Revenue (2017-2028) & (USD Million)
Figure 27. Europe L-Carnosine for Pharmaceutical Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific L-Carnosine for Pharmaceutical Revenue (2017-2028) & (USD Million)
Figure 29. South America L-Carnosine for Pharmaceutical Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa L-Carnosine for Pharmaceutical Revenue (2017-2028) & (USD Million)
Figure 31. Global L-Carnosine for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 32. Global L-Carnosine for Pharmaceutical Revenue Market Share by Type (2017-2028)
Figure 33. Global L-Carnosine for Pharmaceutical Price by Type (2017-2028) & (US$/Ton)
Figure 34. Global L-Carnosine for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 35. Global L-Carnosine for Pharmaceutical Revenue Market Share by Application (2017-2028)
Figure 36. Global L-Carnosine for Pharmaceutical Price by Application (2017-2028) & (US$/Ton)
Figure 37. North America L-Carnosine for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 38. North America L-Carnosine for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 39. North America L-Carnosine for Pharmaceutical Sales Market Share by Country (2017-2028)
Figure 40. North America L-Carnosine for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 41. United States L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe L-Carnosine for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 45. Europe L-Carnosine for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 46. Europe L-Carnosine for Pharmaceutical Sales Market Share by Country (2017-2028)
Figure 47. Europe L-Carnosine for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 48. Germany L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific L-Carnosine for Pharmaceutical Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific L-Carnosine for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific L-Carnosine for Pharmaceutical Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific L-Carnosine for Pharmaceutical Revenue Market Share by Region (2017-2028)
Figure 57. China L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America L-Carnosine for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 64. South America L-Carnosine for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 65. South America L-Carnosine for Pharmaceutical Sales Market Share by Country (2017-2028)
Figure 66. South America L-Carnosine for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 67. Brazil L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa L-Carnosine for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa L-Carnosine for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa L-Carnosine for Pharmaceutical Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa L-Carnosine for Pharmaceutical Revenue Market Share by Region (2017-2028)
Figure 73. Turkey L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa L-Carnosine for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of L-Carnosine for Pharmaceutical in 2021
Figure 78. Manufacturing Process Analysis of L-Carnosine for Pharmaceutical
Figure 79. L-Carnosine for Pharmaceutical Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の医薬品用L-グルタミン市場2022年：市場規模予測（～2028年）
  • 世界のL-カルノシンサプリメント市場2022年：市場規模予測（～2028年）
  • 世界の脱炭酸カルノシンHCL市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用デキストラン市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用ホスファチジルセリン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO6511 )"世界の医薬品用L-カルノシン市場2022年：市場規模予測（～2028年）" (英文：Global L-Carnosine for Pharmaceutical Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。